{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T14:11:52Z","timestamp":1787407912266,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.amjcard.2025.07.011","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T07:47:23Z","timestamp":1752565643000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Lipid-lowering Therapy Utilization, Adherence, and Outcomes Among Adults With and at-Risk for Atherosclerotic Cardiovascular Disease in an Integrated Healthcare Delivery System in Southern California"],"prefix":"10.1016","volume":"255","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0735-0340","authenticated-orcid":false,"given":"Matthew T.","family":"Mefford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Victores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori D.","family":"Bash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaejin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa N.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald D.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2025.07.011_bib0001","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart Disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0002","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart Disease and Stroke statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0003","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0004","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jamacardio.2021.3508","article-title":"Association between cumulative low-density lipoprotein cholesterol exposure during young adulthood and middle age and risk of cardiovascular events","volume":"6","author":"Zhang","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0005","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0006","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of blood Cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0007","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"80","author":"Writing","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0008","article-title":"The importance of low-density lipoprotein cholesterol measurement and control as performance measures: a joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology","volume":"13","author":"Virani","year":"2023","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0009","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011765","article-title":"Patient-reported reasons for declining or discontinuing statin therapy: insights from the PALM registry","volume":"8","author":"Bradley","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCOUTCOMES.122.009787","article-title":"Gaps in guideline-based lipid-lowering therapy for secondary prevention in the United States: a retrospective cohort study of 322 153 patients","volume":"16","author":"Navar","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7812\/TPP\/22.172","article-title":"Comparing Kaiser Permanente members to the general population: implications for generalizability of research","volume":"27","author":"Davis","year":"2023","journal-title":"Perm J"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0012","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0013","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MLR.0b013e3182984c1f","article-title":"Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence","volume":"51","author":"Franklin","year":"2013","journal-title":"Med Care"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0014","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ahj.2017.08.005","article-title":"Lipid management in contemporary community practice: results from the Provider assessment of Lipid Management (PALM) Registry","volume":"193","author":"Navar","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamacardio.2021.1810","article-title":"Use of lipid-lowering therapies over 2 years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US","volume":"6","author":"Cannon","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0017","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.jacc.2019.08.014","article-title":"Therapeutic inertia in cardiovascular disease prevention: time to move the bar","volume":"74","author":"Dixon","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010241","article-title":"Association of Primary Care Providers' Beliefs of statins for Primary prevention and statin prescription","volume":"8","author":"Clough","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0019","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1016\/j.pec.2022.08.005","article-title":"Intensifying approaches to address clinical inertia among cardiovascular disease risk factors: a narrative review","volume":"105","author":"Lewinski","year":"2022","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010376","article-title":"Adherence to statin therapy among US adults between 2007 and 2014","volume":"8","author":"Colantonio","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0021","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ahj.2023.12.010","article-title":"Intensity of and adherence to lipid-lowering therapy as predictors of goal attainment and major adverse cardiovascular events in primary prevention","volume":"269","author":"Mazhar","year":"2024","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0022","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-024-01039-5","article-title":"The LDL cumulative exposure hypothesis: evidence and practical applications","volume":"21","author":"Ference","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0023","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/clc.23935","article-title":"Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease","volume":"46","author":"Desai","year":"2023","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2022.104029","article-title":"Producing personalized statin treatment plans to optimize clinical outcomes using big data and machine learning","volume":"128","author":"Chi","year":"2022","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0025","article-title":"Shared decision making and patient reported outcomes among adults with atherosclerotic cardiovascular disease, medical expenditure panel survey 2006-2015","volume":"8","author":"Okunrintemi","year":"2021","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0026","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12916-024-03527-4","article-title":"Comparative analysis of atherosclerotic cardiovascular disease burden between ages 20-54 and over 55 years: insights from the Global Burden of Disease Study 2019","volume":"22","author":"Li","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0027","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association predicting risk of cardiovascular disease EVENTs (PREVENT) equations","volume":"149","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0028","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014415","article-title":"Cumulative adherence to secondary prevention guidelines and mortality after acute myocardial infarction","volume":"9","author":"Solomon","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0029","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.amepre.2023.04.009","article-title":"Safety net program to improve statin initiation among adults with high low-density lipoprotein cholesterol","volume":"65","author":"Mefford","year":"2023","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.amjcard.2025.07.011_bib0030","series-title":"Kaiser Permanente: Bridging the quality divide with integrated practice, group accountability, and health information technology","author":"McCarthy","year":"2009"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925004059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925004059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T15:11:57Z","timestamp":1763305917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914925004059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"alternative-id":["S0002914925004059"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.07.011","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid-lowering Therapy Utilization, Adherence, and Outcomes Among Adults With and at-Risk for Atherosclerotic Cardiovascular Disease in an Integrated Healthcare Delivery System in Southern California","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Merck & Co., Inc., Rahway, NJ, USA and its affiliates and The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}